We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Data on the real-world efficacy of the COVID-19 vaccines.
How to use a crossover randomised controlled trial to evaluate your digital health product.
How to use a quasi-experimental study to evaluate your digital health product.
How to use an N-of-1 study to evaluate your digital health product.
How to use a before-and-after study to evaluate your digital health product.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
How to use routinely collected data to evaluate your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
Providing vital research into COVID-19 immunity and vaccine effectiveness nationally.
Researchers around the world will soon be able to access millions of the natural, historic specimens found in UK museums at the click of a button as part of a £473 million UK fund to enhance key research infrastructure.
Using an ecological momentary assessment to evaluate your digital health product.
How to use a cost utility analysis to evaluate your digital health product.
An outline of the delivery patterns that are outside of standard delivery.
View highlights of some of our most recently published research on this page. You can also download a complete list of our published research.
Summary of the government's ongoing programme of work addressing key issues identified by the DCMS Select Committee’s Inquiry into the Economics of Music Streaming, including an indicative timeline for upcoming milestones.
Results for the Vivaldi study for antibody and cellular immune responses to coronavirus (COVID-19) in approximately 340 care homes.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
UKHSA and ONS have today published the latest data from the Winter Coronavirus (COVID-19) Infection Study, known as the Winter CIS.
How to use feedback from marketplace reviews to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).